They offer steady enterprise stability, excellent benefits, and a high-impact mission in life sciences, though bureaucratic layers can slow individual momentum. AbbVie is a publicly traded biopharmaceutical giant headquartered in North Chicago, Illinois. Founded in 2013 following a spinoff from Abbott Laboratories, they operate an extensive global network of manufacturing and research facilities across North America, Europe, and Asia. Their core business centers on discovering and commercializing specialized medicines across immunology, oncology, neuroscience, and aesthetics.
Is this a good match for you?
Unlock your full match with Apt ProStart with the AI-powered career test to unlock your personal career mentor, full company insights, and a personalized job board designed around your goals.
About
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience – and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com. Follow @abbvie on LinkedIn, Facebook, Instagram, X and YouTube.
Generous compensation and wellness benefitsHigh-impact global drug research programsRelatively strong job security in pharma
Why leave
Heavy and politically driven middle managementLimited paths for internal career advancementStrict mandates on in-office presence
Company Pulse
Headcount
-6%past year
Raised
$23.0Btotal
Recent: $15.0B raised
In the News
AbbVie (ABBV) Wins A New Lymphoma Nod, Is The Stock Still Cheap? - Simply Wall St Newssimplywall.st · Sep 25, 2026
AbbVie’s top lawyer publicly makes the case against German pricing - BioPharmaDispatchpharmadispatch.com · Sep 24, 2026
Abbvie Inc.: AbbVie : Participates in USTR’s Section 301 Investigation into Germany to Address Global Imbalances in How ... | 6ix News6ix.com · Sep 22, 2026
AbbVie and Iambic Announce Collaboration to Accelerate AI-driven Drug Discoveryprnewswire.com · Sep 21, 2026
Strong benefitsCompensation and benefits rating sits at an impressive 80 out of 100.
Strategic M&ACompleted a $10.9 billion acquisition of Apogee Therapeutics to bolster immunology assets.
Watch out
Leadership frictionSenior management scores lag behind other metrics with a 68 out of 100 rating.
Note
Executive leadershipLed by CEO Robert A. Michael, maintaining an 80 rating across staff reviews.
Things to consider
Middle management friction — Employees frequently report heavy management layers, internal politics, and slow movement on promotions without senior executive sponsorship.
Strict in-office enforcement — Recent return-to-office requirements have frustrated suburban commuters and reduced operational flexibility for distributed teams.
Leadership
RA
Robert A. MichaelChairman of the Board and Chief Executive Officer
What They Build
AbbVie builds advanced biotherapeutics, small molecule compounds, and data-driven platforms for drug discovery and clinical development. Engineering and informatics teams manage high-throughput genomic data, enterprise manufacturing systems, and cloud pipelines to support translational research. Their technical efforts increasingly emphasize automated laboratory operations, predictive modeling, and AI-accelerated molecular design.